Literature DB >> 22205015

Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED.

Ching-Chi Lee1, Chung-Hsun Lee, Ming-Che Chuang, Ming-Yuan Hong, Hsiang-Chin Hsu, Wen-Chien Ko.   

Abstract

OBJECTIVES: To investigate the clinical impact of inappropriate empirical antibiotics on patient outcome and determine the risk factors for mortality in bacteremic adults who visited the emergency department (ED).
METHODS: Bacteremic adults visiting the ED from January 2007 to June 2008 were identified retrospectively. Demographic characteristics, clinical conditions, bacteremic pathogens, antimicrobial agents, and outcomes were determined from chart records.
RESULTS: The total of 454 eligible bacteremic adults were included in the analysis; excluded from the study were another 261 patients with contaminated blood cultures and 64 patients with ED stays of less than 24 hours. Among the included individuals, the mean age was 64.6 years, with a small predominance of males (230 patients, 50.7%). Of a total 494 bacteremic isolates, Escherichia coli (206, 41.7%) and Klebsiella species (81, 16.4%) were the most frequently encountered microorganisms. A lower 28-day mortality rate was demonstrated in bacteremic patients treated with appropriate antibiotics than that in those with inappropriate antibiotics or that in those with no antibiotic therapy, as judged by Kaplan-Meier survival curves (P = .01). Moreover, the differences among these three groups achieved higher significance (P = .002) in critically ill patients (Pittsburgh bacteremia scores of ≥ 4 points). In multivariate analyses, inappropriate antibiotic therapy in the ED was associated independently with mortality at 28 days (odds ratio, 2.26; 95% confidence interval, 1.01-5.13; P = .04).
CONCLUSIONS: For bacteremic adults visiting the ED, their outcomes were favorable following appropriate antibiotics, compared to treatment with inappropriate antibiotics or no antibiotics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205015     DOI: 10.1016/j.ajem.2011.11.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  18 in total

1.  Evaluation of community-acquired sepsis by PIRO system in the emergency department.

Authors:  Yun-Xia Chen; Chun-Sheng Li
Journal:  Intern Emerg Med       Date:  2013-06-16       Impact factor: 3.397

2.  Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systems.

Authors:  Jonathan H K Chen; Pak-Leung Ho; Grace S W Kwan; Kevin K K She; Gilman K H Siu; Vincent C C Cheng; Kwok-Yung Yuen; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2013-03-20       Impact factor: 5.948

3.  Improving the appropriateness of antimicrobial use in primary care after implementation of a local antimicrobial guide in both levels of care.

Authors:  Rocío Fernández Urrusuno; Macarena Flores Dorado; Angel Vilches Arenas; Carmen Serrano Martino; Susana Corral Baena; Ma Carmen Montero Balosa
Journal:  Eur J Clin Pharmacol       Date:  2014-06-03       Impact factor: 2.953

4.  Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.

Authors:  Ching-Chi Lee; Jiun-Ling Wang; Chung-Hsun Lee; Chih-Chia Hsieh; Yuan-Pin Hung; Ming-Yuan Hong; Hung-Jen Tang; Wen-Chien Ko
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision.

Authors:  Ying Wang; Xinping Zhang; Xuemei Wang; Xiaoquan Lai
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

6.  Evaluation of an infectious disease consultation programme in a German tertiary care hospital.

Authors:  J J Vehreschild; G Morgen; O A Cornely; P Hartmann; S Koch; W Kalka-Moll; C Wyen; M J G T Vehreschild; C Lehmann; D Gillor; H Seifert; G Kremer; G Fätkenheuer; N Jung
Journal:  Infection       Date:  2013-08-08       Impact factor: 3.553

7.  Performance Evaluation of the Verigene Gram-Positive and Gram-Negative Blood Culture Test for Direct Identification of Bacteria and Their Resistance Determinants from Positive Blood Cultures in Hong Kong.

Authors:  Gilman K H Siu; Jonathan H K Chen; T K Ng; Rodney A Lee; Kitty S C Fung; Sabrina W C To; Barry K C Wong; Sherman Cheung; Ivan W F Wong; Marble M P Tam; Swing S W Lee; W C Yam
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

8.  The impact of inappropriate antibiotics on bacteremia patients in a community hospital in Taiwan: an emphasis on the impact of referral information for cases from a hospital affiliated nursing home.

Authors:  Chih-Jen Yang; Yu-Chieh Chung; Tun-Chieh Chen; Hsu-Liang Chang; Ying-Ming Tsai; Ming-Shyan Huang; Yen-Hsu Chen; Po-Liang Lu
Journal:  BMC Infect Dis       Date:  2013-10-24       Impact factor: 3.090

9.  Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.

Authors:  Tsung-Hang Kuo; Chao-Yung Yang; Chung-Hsun Lee; Chih-Chia Hsieh; Wen-Chien Ko; Ching-Chi Lee
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

10.  Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia.

Authors:  Ching-Chi Lee; Chung-Hsun Lee; Ming-Yuan Hong; Hung-Jen Tang; Wen-Chien Ko
Journal:  Crit Care       Date:  2017-05-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.